PubMed:24737316 / 0-230 JSONTXT

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"GlycoEpitope"}],"attributes":[{"id":"A1","pred":"glyco_epitope_db_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0050"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":74},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"https://glytoucan.org/Structures/Glycans/G46613JI"},{"id":"T2","span":{"begin":75,"end":78},"obj":"https://glytoucan.org/Structures/Glycans/G48558GR"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":187,"end":202},"obj":"gene:2720"},{"id":"T1","span":{"begin":98,"end":115},"obj":"disease:C0086652"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":120,"end":139},"obj":"HP_0000007"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"Allie","denotations":[{"id":"SS1_24737316_1_0","span":{"begin":187,"end":202},"obj":"expanded"},{"id":"SS2_24737316_1_0","span":{"begin":204,"end":209},"obj":"abbr"}],"relations":[{"id":"AE1_24737316_1_0","pred":"abbreviatedTo","subj":"SS1_24737316_1_0","obj":"SS2_24737316_1_0"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"24737316-1#112#127#gene2720","span":{"begin":187,"end":202},"obj":"gene2720"},{"id":"24737316-1#129#134#gene2720","span":{"begin":204,"end":209},"obj":"gene2720"},{"id":"24737316-1#23#40#diseaseC0086652","span":{"begin":98,"end":115},"obj":"diseaseC0086652"}],"relations":[{"id":"112#127#gene272023#40#diseaseC0086652","pred":"associated_with","subj":"24737316-1#112#127#gene2720","obj":"24737316-1#23#40#diseaseC0086652"},{"id":"129#134#gene272023#40#diseaseC0086652","pred":"associated_with","subj":"24737316-1#129#134#gene2720","obj":"24737316-1#23#40#diseaseC0086652"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":75,"end":93},"obj":"Disease"},{"id":"T2","span":{"begin":120,"end":148},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0018149"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0006025"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G48558GR"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0050"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":75,"end":93},"obj":"Disease"},{"id":"T2","span":{"begin":120,"end":148},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0018149"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0006025"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T1","span":{"begin":52,"end":57},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":74},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":74},"obj":"Sentence"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G48558GR"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":75,"end":78},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0050"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}

{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":52,"end":57},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"Structural basis of pharmacological chaperoning for human β-galactosidase.\nGM1 gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal β-galactosidase (β-Gal), frequently related"}